PortfoliosLab logoPortfoliosLab logo
MRK vs. SAN.PA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MRK vs. SAN.PA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Sanofi (SAN.PA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

MRK is traded in USD, while SAN.PA is traded in EUR. To make them comparable, the SAN.PA values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, MRK achieves a 13.94% return, which is significantly higher than SAN.PA's -3.72% return. Over the past 10 years, MRK has outperformed SAN.PA with an annualized return of 11.59%, while SAN.PA has yielded a comparatively lower 5.80% annualized return.


MRK

1D
-1.42%
1M
4.97%
YTD
13.94%
6M
20.60%
1Y
50.99%
3Y*
5.87%
5Y*
12.81%
10Y*
11.59%

SAN.PA

1D
0.27%
1M
3.65%
YTD
-3.72%
6M
-4.37%
1Y
-6.70%
3Y*
0.11%
5Y*
0.28%
10Y*
5.80%
*Multi-year figures are annualized to reflect compound growth (CAGR)

MRK vs. SAN.PA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MRK
Merck & Co., Inc.
13.94%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%
SAN.PA
Sanofi
-3.72%4.51%2.04%6.91%-1.39%8.90%-0.91%21.02%5.21%10.15%

Correlation

The correlation between MRK and SAN.PA is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.39

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2007

0.32

The correlation between MRK and SAN.PA shifts across timeframes, from 0.28 (5 years) to 0.39 (1 year), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MRK vs. SAN.PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRK
MRK Risk / Return Rank: 8888
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8888
Sortino Ratio Rank
MRK Omega Ratio Rank: 8585
Omega Ratio Rank
MRK Calmar Ratio Rank: 9191
Calmar Ratio Rank
MRK Martin Ratio Rank: 9090
Martin Ratio Rank

SAN.PA
SAN.PA Risk / Return Rank: 2626
Overall Rank
SAN.PA Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
SAN.PA Sortino Ratio Rank: 2525
Sortino Ratio Rank
SAN.PA Omega Ratio Rank: 2525
Omega Ratio Rank
SAN.PA Calmar Ratio Rank: 2727
Calmar Ratio Rank
SAN.PA Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRK vs. SAN.PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Sanofi (SAN.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MRKSAN.PADifference
Sharpe ratioReturn per unit of total volatility

+2.19

Sortino ratioReturn per unit of downside risk

+3.06

Omega ratioGain probability vs. loss probability

1.33

0.97

+0.37

Calmar ratioReturn relative to maximum drawdown

4.49

-0.45

+4.94

Martin ratioReturn relative to average drawdown

11.22

-0.90

+12.11

MRK vs. SAN.PA - Sharpe Ratio Comparison

The current MRK Sharpe Ratio is 1.88, which is higher than the SAN.PA Sharpe Ratio of -0.31. The chart below compares the historical Sharpe Ratios of MRK and SAN.PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MRK vs. SAN.PA - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.61%, which is greater than SAN.PA's maximum drawdown of -47.80%. Use the drawdown chart below to compare losses from any high point for MRK and SAN.PA.


Loading charts...

Drawdown Indicators


MRKSAN.PADifference

Max Drawdown

Largest peak-to-trough decline

-68.61%

-47.80%

-20.81%

Max Drawdown (1Y)

Largest decline over 1 year

-11.37%

-17.16%

+5.79%

Max Drawdown (3Y)

Largest decline over 3 years

-43.44%

-23.35%

-20.09%

Max Drawdown (5Y)

Largest decline over 5 years

-43.44%

-33.52%

-9.92%

Max Drawdown (10Y)

Largest decline over 10 years

-43.44%

-33.52%

-9.92%

Current Drawdown

Current decline from peak

-5.03%

-17.74%

+12.71%

Average Drawdown

Average peak-to-trough decline

-18.83%

-13.03%

-5.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.54%

8.68%

-4.14%

Volatility

MRK vs. SAN.PA - Volatility Comparison

Merck & Co., Inc. (MRK) has a higher volatility of 9.57% compared to Sanofi (SAN.PA) at 6.61%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than SAN.PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MRKSAN.PADifference

Volatility (1M)

Calculated over the trailing 1-month period

9.57%

6.61%

+2.96%

Volatility (6M)

Calculated over the trailing 6-month period

18.04%

16.06%

+1.98%

Volatility (1Y)

Calculated over the trailing 1-year period

27.18%

25.15%

+2.03%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.66%

23.92%

-0.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.96%

22.30%

+0.66%

Dividends

MRK vs. SAN.PA - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 2.79%, less than SAN.PA's 5.38% yield.


PositionTTM20252024202320222021202020192018201720162015
MRK
Merck & Co., Inc.
2.79%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%
SAN.PA
Sanofi
5.38%4.74%4.01%3.97%3.71%3.61%4.00%3.43%4.00%4.12%3.81%3.63%

Financials

MRK vs. SAN.PA - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Sanofi. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. MRK values in USD, SAN.PA values in EUR

Frequently Asked Questions


MRK and SAN.PA have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for MRK and SAN.PA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer